Medtronic PLC Asset Resilience Ratio
Medtronic PLC asset resilience ratio. Medtronic PLC (MDT) has an Asset Resilience Ratio of 7.82% as of April 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Medtronic PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Medtronic PLC (1999–2026)
Asset resilience ratio of Medtronic PLC from 1999 to 2026. This chart shows how Medtronic PLC's Asset Resilience Ratio has changed over time. Read MDT current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Medtronic PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Medtronic PLC.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $7.27 Billion | 7.82% |
| Total Liquid Assets | $7.27 Billion | 7.82% |
Asset Resilience Insights
- Limited Liquidity: Medtronic PLC maintains only 7.82% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medtronic PLC Industry Peers by Asset Resilience Ratio
Compare Medtronic PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Getein Biotech Inc
SHG:603387 |
Medical Devices | 29.77% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
Medtronic PLC Asset Resilience Ratio by Year (1999–2026)
Medtronic PLC asset resilience ratio by year from 1999 to 2026. The table below shows the annual Asset Resilience Ratio data for Medtronic PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-04-30 | 7.82% | $7.27 Billion | $93.03 Billion | -1.96pp |
| 2025-04-30 | 9.78% | $8.96 Billion | $91.68 Billion | +0.88pp |
| 2024-04-30 | 8.90% | $8.01 Billion | $89.98 Billion | +0.15pp |
| 2023-04-30 | 8.75% | $7.96 Billion | $90.95 Billion | -2.87pp |
| 2022-04-30 | 11.62% | $10.57 Billion | $90.98 Billion | +0.00pp |
| 2021-04-30 | 11.62% | $10.82 Billion | $93.08 Billion | -0.45pp |
| 2020-04-30 | 12.07% | $10.95 Billion | $90.69 Billion | +1.09pp |
| 2019-04-30 | 10.98% | $9.85 Billion | $89.69 Billion | -1.30pp |
| 2018-04-30 | 12.28% | $11.23 Billion | $91.39 Billion | -1.45pp |
| 2017-04-30 | 13.73% | $13.71 Billion | $99.82 Billion | +3.93pp |
| 2016-04-30 | 9.80% | $9.76 Billion | $99.55 Billion | -3.92pp |
| 2015-04-30 | 13.72% | $14.64 Billion | $106.69 Billion | -20.12pp |
| 2014-04-30 | 33.83% | $12.84 Billion | $37.94 Billion | +4.84pp |
| 2013-04-30 | 28.99% | $10.09 Billion | $34.79 Billion | +24.93pp |
| 2012-04-30 | 4.06% | $1.34 Billion | $33.08 Billion | +0.62pp |
| 2011-04-30 | 3.44% | $1.05 Billion | $30.42 Billion | -5.02pp |
| 2010-04-30 | 8.45% | $2.38 Billion | $28.09 Billion | +6.74pp |
| 2009-04-30 | 1.71% | $405.00 Million | $23.66 Billion | -0.78pp |
| 2008-04-30 | 2.49% | $553.00 Million | $22.20 Billion | -6.85pp |
| 2007-04-30 | 9.34% | $1.82 Billion | $19.51 Billion | -6.46pp |
| 2006-04-30 | 15.80% | $3.11 Billion | $19.66 Billion | +8.82pp |
| 2005-04-30 | 6.98% | $1.16 Billion | $16.62 Billion | +4.61pp |
| 2004-04-30 | 2.37% | $333.80 Million | $14.11 Billion | +2.18pp |
| 2003-04-30 | 0.18% | $22.70 Million | $12.32 Billion | -0.94pp |
| 2002-04-30 | 1.13% | $123.00 Million | $10.90 Billion | -1.73pp |
| 2001-04-30 | 2.86% | $201.40 Million | $7.04 Billion | +0.93pp |
| 2000-04-30 | 1.93% | $109.70 Million | $5.67 Billion | -1.22pp |
| 1999-04-30 | 3.16% | $153.80 Million | $4.87 Billion | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardiovert… Read more